NASA developed the ventilator, dubbed the Ventilator Intervention Technology Accessible Locally, as part of its NASA@Work initiative. The program encouraged NASA employees to submit prospective projects in support of COVID-19 medical responses.
VITAL uses one-seventh of the parts of a traditional ventilator and relies on parts already available in supply chains. The FDA on April 30 granted emergency use authorization of the device, which is designed to last for three to four months and provide respiratory support for patients with respiratory failure or insufficiency. VITAL was tested at New York City-based Mount Sinai Health System.
The U.S. companies NASA selected for licenses to make VITAL are:
- Vacumed
- Stark Industries
- MVent
- iButtonLink
- Evo Design
- DesignPlex Biomedical
- Atron Group
- Pro-Dex
More articles on digital transformation:
The pandemic accelerated tech-driven healthcare delivery; will it last? Key thoughts from Summa Health CIO Tanya Arthur
Livongo proposes $400M offering: 3 details
UPMC has invested $800M in digital health, entrepreneurial efforts for a $1.5B return
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.